How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/recombinant-thyroid-stimulating-hormone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

recombinant thyroid-stimulating hormone — Competitive Intelligence Brief

recombinant thyroid-stimulating hormone (recombinant thyroid-stimulating hormone) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Glycoprotein hormone. Area: Endocrinology.

phase 3 Glycoprotein hormone Thyrotropin receptor Endocrinology Biologic Live · refreshed every 30 min

Target snapshot

recombinant thyroid-stimulating hormone (recombinant thyroid-stimulating hormone) — University College, London. Recombinant thyroid-stimulating hormone (TSH) is a synthetic form of the hormone TSH, which stimulates the thyroid gland to produce thyroid hormones.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
recombinant thyroid-stimulating hormone TARGET	recombinant thyroid-stimulating hormone	University College, London	phase 3	Glycoprotein hormone	Thyrotropin receptor
Thyrogen	THYROTROPIN ALFA	Sanofi	marketed	Adrenocorticotropic Hormone [EPC]	Thyrotropin receptor	1953-01-01
Thyrogen	Thyrogen	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	marketed	Recombinant human thyrotropin	Thyrotropin receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Glycoprotein hormone class)

University College, London · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). recombinant thyroid-stimulating hormone — Competitive Intelligence Brief. https://druglandscape.com/ci/recombinant-thyroid-stimulating-hormone. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab